Frode Nilsen

Akershus University Hospital

Papers

2

Total Citations

16

H-Index

2

About

Frode Nilsen is a prominent urologic surgeon and researcher whose work centers on renal cancer, prostate cancer, and the evolution of minimal access surgery. He is a founding member of the Nordic Renal Cancer Group (NORENCA), a collaborative network uniting the five Nordic countries to standardize and improve renal tumor treatment. His landmark study, the NORENCA-I survey (2017), provided the first comprehensive snapshot of contemporary renal cancer management across 25 million people, revealing critical variations in surgical approaches and setting the stage for future Nordic trials. In prostate cancer, Nilsen has been a leading voice on robotic surgery, authoring a seminal 2014 review that critically assessed the rapid adoption of robotic-assisted radical prostatectomy. His work highlights both the transformative potential of robotic technology and the missed opportunities for rigorous prospective trials during its dissemination. With a career dedicated to evidence-based surgical innovation, Nilsen’s research continues to shape clinical guidelines and foster international collaboration, making him a key figure in advancing urologic oncology in Scandinavia.

Research Focus

Key Achievements

2
H-Index
2
Papers
16
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)
9 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Akershus University Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago